203
Participants
Start Date
October 12, 2021
Primary Completion Date
July 20, 2022
Study Completion Date
July 28, 2022
T-Detect COVID test
• The T-DetectTM COVID test is an EUA granted investigational device that is indicated to assess a T-cell immune response to SARS-CoV-2 via the testing of blood samples from patients with signs and symptoms of suspected COVID-19.
Decentralized Clinical Trial Model- New York City, New York
Decentralized Trial Model - Washington D.C., Washington D.C.
Decentralized Trial Model- California, San Diego
Decentralized Trial Model- Florida, Miami
Decentralized Trial Model- Denver, Denver
Decentralized Trial Model- Utah, Salt Lake City
Decentralized Trial Model- Phoenix, Phoenix
Decentralized Trial Model- California, Los Angeles
Decentralized Trial Model- Fullerton, Fullerton
Decentralized Trial Model- San Francisco, San Francisco
Decentralized Trial Model- Sacramento, Sacramento
Decentralized Trial Model- Modesto, Modesto
Decentralized Trial Model- Portland, Portland
Decentralized Trial Model- Seattle, Seattle
Decentralized Trial Model- Vancouver, WA, Vancouver
Lead Sponsor
Adaptive Biotechnologies
INDUSTRY